Source link : https://newshealth.biz/health-news/first-in-class-vepdegestrant-approved-in-advanced-breast-cancer/
The FDA approved oral vepdegestrant (Veppanu) for adults with advanced or metastatic estrogen receptor (ER)-positive/HER2-negative breast cancer, the agency announced on Friday. Approval of the first-in-class proteolysis targeting chimera (PROTAC) — a type of heterobifunctional protein degrader therapy — stipulates use in patients with ESR1-mutated disease that has progressed following at least one line of […]
The post First-in-Class Vepdegestrant Approved in Advanced Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-01 18:32:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8